Market Tracker

12/19 3:15pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.75
Data as of 2:56pm ET
 +0.003 / +0.40%
Today’s Change
0.53
Today|||52-Week Range
1.58
-18.92%
Year-to-Date

Today’s Trading

Previous close0.75
Today’s open0.72
Day’s range0.72 - 0.75
Volume192,698
Average volume (3 months)496,587
Market cap$46.9M
Dividend yield--
Data as of 2:56pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+54.29%
Earnings growth (this year)-6.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
BCLIBrainstorm Cell Ther...-0.13-3.78%
CASICASI Pharmaceuticals...-0.05-4.00%
AEZSAEterna Zentaris Inc-0.00-0.61%
PBMDPrima BioMed Ltd-0.01-1.08%
Data as of 3:11pm ET, 12/19/2014

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts